Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model
Teuku H,Andri WT,Siswanto BB,Santoso A,Sukmawan R,Sargowo D, et al.Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model. Journal of Cardiovascular Disease Research. 2017;8(2):xx-xx.
Source: Journal of Cardiovascular Disease Research - Category: Cardiology Authors: nandan Tags: Darapladib inflammation Lipoprotein-associated phospholipase A2 oxidative stress Type 2 diabetes mellitus Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart